|
Aguilar, E., Marin de Mas, I., Zodda, E., Marin, S., Morrish, F., Selivanov, V., Meca-Cortes, O., Delowar, H., Pons, M., Izquierdo, I., et al. (2016). Metabolic Reprogramming and Dependencies Associated with Epithelial Cancer Stem Cells Independent of the Epithelial-Mesenchymal Transition Program. Stem cells (Dayton, Ohio) 34, 1163-1176.
Allton, K., Jain, A.K., Herz, H.M., Tsai, W.W., Jung, S.Y., Qin, J., Bergmann, A., Johnson, R.L., and Barton, M.C. (2009). Trim24 targets endogenous p53 for degradation. Proceedings of the National Academy of Sciences of the United States of America 106, 11612-11616.
Alo, P.L., Visca, P., Botti, C., Galati, G.M., Sebastiani, V., Andreano, T., Di Tondo, U., and Pizer, E.S. (2001). Immunohistochemical expression of human erythrocyte glucose transporter and fatty acid synthase in infiltrating breast carcinomas and adjacent typical/atypical hyperplastic or normal breast tissue. American journal of clinical pathology 116, 129-134.
Augustin, R., Carayannopoulos, M.O., Dowd, L.O., Phay, J.E., Moley, J.F., and Moley, K.H. (2004). Identification and characterization of human glucose transporter-like protein-9 (GLUT9): alternative splicing alters trafficking. The Journal of biological chemistry 279, 16229-16236.
Binder, C., Binder, L., Marx, D., Schauer, A., and Hiddemann, W. (1997). Deregulated simultaneous expression of multiple glucose transporter isoforms in malignant cells and tissues. Anticancer research 17, 4299-4304.
Boado, R.J., Black, K.L., and Pardridge, W.M. (1994). Gene expression of GLUT3 and GLUT1 glucose transporters in human brain tumors. Brain research Molecular brain research 27, 51-57.
Browman, G.P., Wong, G., Hodson, I., Sathya, J., Russell, R., McAlpine, L., Skingley, P., and Levine, M.N. (1993). Influence of cigarette smoking on the efficacy of radiation therapy in head and neck cancer. The New England journal of medicine 328, 159-163.
Brown, R.S., and Wahl, R.L. (1993). Overexpression of Glut-1 glucose transporter in human breast cancer. An immunohistochemical study. Cancer 72, 2979-2985.
Burant, C.F., Takeda, J., Brot-Laroche, E., Bell, G.I., and Davidson, N.O. (1992). Fructose transporter in human spermatozoa and small intestine is GLUT5. The Journal of biological chemistry 267, 14523-14526.
Byrne, F.L., Poon, I.K., Modesitt, S.C., Tomsig, J.L., Chow, J.D., Healy, M.E., Baker, W.D., Atkins, K.A., Lancaster, J.M., Marchion, D.C., et al. (2014). Metabolic vulnerabilities in endometrial cancer. Cancer research 74, 5832-5845.
Chambon, M., Orsetti, B., Berthe, M.L., Bascoul-Mollevi, C., Rodriguez, C., Duong, V., Gleizes, M., Thenot, S., Bibeau, F., Theillet, C., et al. (2011). Prognostic significance of TRIM24/TIF-1alpha gene expression in breast cancer. The American journal of pathology 178, 1461-1469.
Chan, K.K., Chan, J.Y., Chung, K.K., and Fung, K.P. (2004). Inhibition of cell proliferation in human breast tumor cells by antisense oligonucleotides against facilitative glucose transporter 5. Journal of cellular biochemistry 93, 1134-1142.
Chandler, J.D., Williams, E.D., Slavin, J.L., Best, J.D., and Rogers, S. (2003). Expression and localization of GLUT1 and GLUT12 in prostate carcinoma. Cancer 97, 2035-2042.
Chen, J.Y., Chang, Y.L., Yu, Y.C., Chao, C.C., Kao, H.W., Wu, C.T., Lin, W.C., Ko, J.Y., and Jou, Y.S. (2004). Specific induction of the high-molecular-weight microtubule-associated protein 2 (hmw-MAP2) by betel quid extract in cultured oral keratinocytes: clinical implications in betel quid-associated oral squamous cell carcinoma (OSCC). Carcinogenesis 25, 269-276.
Christen, R.D., Hom, D.K., Porter, D.C., Andrews, P.A., MacLeod, C.L., Hafstrom, L., and Howell, S.B. (1990). Epidermal growth factor regulates the in vitro sensitivity of human ovarian carcinoma cells to cisplatin. The Journal of clinical investigation 86, 1632-1640.
Colville, C.A., Seatter, M.J., Jess, T.J., Gould, G.W., and Thomas, H.M. (1993). Kinetic analysis of the liver-type (GLUT2) and brain-type (GLUT3) glucose transporters in Xenopus oocytes: substrate specificities and effects of transport inhibitors. The Biochemical journal 290 ( Pt 3), 701-706.
Conde, V.R., Oliveira, P.F., Nunes, A.R., Rocha, C.S., Ramalhosa, E., Pereira, J.A., Alves, M.G., and Silva, B.M. (2015). The progression from a lower to a higher invasive stage of bladder cancer is associated with severe alterations in glucose and pyruvate metabolism. Experimental cell research 335, 91-98.
Cui, X.F., Imaizumi, T., Yoshida, H., Borden, E.C., and Satoh, K. (2004). Retinoic acid-inducible gene-I is induced by interferon-gamma and regulates the expression of interferon-gamma stimulated gene 15 in MCF-7 cells. Biochemistry and cell biology = Biochimie et biologie cellulaire 82, 401-405.
Cui, Z., Cao, W., Li, J., Song, X., Mao, L., and Chen, W. (2013). TRIM24 overexpression is common in locally advanced head and neck squamous cell carcinoma and correlates with aggressive malignant phenotypes. PloS one 8, e63887.
Dawson, P.A., Mychaleckyj, J.C., Fossey, S.C., Mihic, S.J., Craddock, A.L., and Bowden, D.W. (2001). Sequence and functional analysis of GLUT10: a glucose transporter in the Type 2 diabetes-linked region of chromosome 20q12-13.1. Molecular genetics and metabolism 74, 186-199.
de Geus-Oei, L.F., van Krieken, J.H., Aliredjo, R.P., Krabbe, P.F., Frielink, C., Verhagen, A.F., Boerman, O.C., and Oyen, W.J. (2007). Biological correlates of FDG uptake in non-small cell lung cancer. Lung cancer (Amsterdam, Netherlands) 55, 79-87.
Doblado, M., and Moley, K.H. (2009). Facilitative glucose transporter 9, a unique hexose and urate transporter. American journal of physiology Endocrinology and metabolism 297, E831-835.
Doege, H., Bocianski, A., Joost, H.G., and Schurmann, A. (2000). Activity and genomic organization of human glucose transporter 9 (GLUT9), a novel member of the family of sugar-transport facilitators predominantly expressed in brain and leucocytes. The Biochemical journal 350 Pt 3, 771-776.
Evans, S.A., Doblado, M., Chi, M.M., Corbett, J.A., and Moley, K.H. (2009). Facilitative glucose transporter 9 expression affects glucose sensing in pancreatic beta-cells. Endocrinology 150, 5302-5310.
Fraser, R.A., Heard, D.J., Adam, S., Lavigne, A.C., Le Douarin, B., Tora, L., Losson, R., Rochette-Egly, C., and Chambon, P. (1998). The putative cofactor TIF1alpha is a protein kinase that is hyperphosphorylated upon interaction with liganded nuclear receptors. The Journal of biological chemistry 273, 16199-16204.
Fukuzumi, M., Hamakawa, H., Onishi, A., Sumida, T., and Tanioka, H. (2000). Gene expression of GLUT isoforms and VHL in oral squamous cell carcinoma. Cancer letters 161, 133-140.
Ganapathy, V., Thangaraju, M., and Prasad, P.D. (2009). Nutrient transporters in cancer: relevance to Warburg hypothesis and beyond. Pharmacology & therapeutics 121, 29-40.
Garrido, P., Osorio, F.G., Moran, J., Cabello, E., Alonso, A., Freije, J.M., and Gonzalez, C. (2015). Loss of GLUT4 induces metabolic reprogramming and impairs viability of breast cancer cells. Journal of cellular physiology 230, 191-198.
Godoy, A., Ulloa, V., Rodriguez, F., Reinicke, K., Yanez, A.J., Garcia Mde, L., Medina, R.A., Carrasco, M., Barberis, S., Castro, T., et al. (2006). Differential subcellular distribution of glucose transporters GLUT1-6 and GLUT9 in human cancer: ultrastructural localization of GLUT1 and GLUT5 in breast tumor tissues. Journal of cellular physiology 207, 614-627.
Goldman, N.A., Katz, E.B., Glenn, A.S., Weldon, R.H., Jones, J.G., Lynch, U., Fezzari, M.J., Runowicz, C.D., Goldberg, G.L., and Charron, M.J. (2006). GLUT1 and GLUT8 in endometrium and endometrial adenocarcinoma. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 19, 1429-1436.
Gomez, O., Ballester-Lurbe, B., Poch, E., Mesonero, J.E., and Terrado, J. (2010). Developmental regulation of glucose transporters GLUT3, GLUT4 and GLUT8 in the mouse cerebellar cortex. Journal of anatomy 217, 616-623.
Grivennikov, S.I., Greten, F.R., and Karin, M. (2010). Immunity, inflammation, and cancer. Cell 140, 883-899.
Guillam, M.T., Dupraz, P., and Thorens, B. (2000). Glucose uptake, utilization, and signaling in GLUT2-null islets. Diabetes 49, 1485-1491.
Guo, L., Li, L., Wang, W., Pan, Z., Zhou, Q., and Wu, Z. (2012). Mitochondrial reactive oxygen species mediates nicotine-induced hypoxia-inducible factor-1alpha expression in human non-small cell lung cancer cells. Biochimica et biophysica acta 1822, 852-861.
Haber, R.S., Weinstein, S.P., O'Boyle, E., and Morgello, S. (1993). Tissue distribution of the human GLUT3 glucose transporter. Endocrinology 132, 2538-2543.
Hatakeyama, S. (2011). TRIM proteins and cancer. Nature reviews Cancer 11, 792-804.
Higashi, T., Tamaki, N., Honda, T., Torizuka, T., Kimura, T., Inokuma, T., Ohshio, G., Hosotani, R., Imamura, M., and Konishi, J. (1997). Expression of glucose transporters in human pancreatic tumors compared with increased FDG accumulation in PET study. Journal of nuclear medicine : official publication, Society of Nuclear Medicine 38, 1337-1344.
Hoff, C.M., Grau, C., and Overgaard, J. (2012). Effect of smoking on oxygen delivery and outcome in patients treated with radiotherapy for head and neck squamous cell carcinoma--a prospective study. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 103, 38-44.
Huang, S., Lifshitz, L.M., Jones, C., Bellve, K.D., Standley, C., Fonseca, S., Corvera, S., Fogarty, K.E., and Czech, M.P. (2007). Insulin stimulates membrane fusion and GLUT4 accumulation in clathrin coats on adipocyte plasma membranes. Molecular and cellular biology 27, 3456-3469.
Ibberson, M., Uldry, M., and Thorens, B. (2000). GLUTX1, a novel mammalian glucose transporter expressed in the central nervous system and insulin-sensitive tissues. The Journal of biological chemistry 275, 4607-4612.
Itahana, Y., Han, R., Barbier, S., Lei, Z., Rozen, S., and Itahana, K. (2015). The uric acid transporter SLC2A9 is a direct target gene of the tumor suppressor p53 contributing to antioxidant defense. Oncogene 34, 1799-1810.
James, D.E., Brown, R., Navarro, J., and Pilch, P.F. (1988). Insulin-regulatable tissues express a unique insulin-sensitive glucose transport protein. Nature 333, 183-185.
Jemal, A., Siegel, R., Ward, E., Hao, Y., Xu, J., and Thun, M.J. (2009). Cancer statistics, 2009. CA: a cancer journal for clinicians 59, 225-249.
Jiang, S., Minter, L.C., Stratton, S.A., Yang, P., Abbas, H.A., Akdemir, Z.C., Pant, V., Post, S., Gagea, M., Lee, R.G., et al. (2015). TRIM24 suppresses development of spontaneous hepatic lipid accumulation and hepatocellular carcinoma in mice. Journal of hepatology 62, 371-379.
Johnson, J.H., Newgard, C.B., Milburn, J.L., Lodish, H.F., and Thorens, B. (1990). The high Km glucose transporter of islets of Langerhans is functionally similar to the low affinity transporter of liver and has an identical primary sequence. The Journal of biological chemistry 265, 6548-6551.
Kamata, N., Chida, K., Rikimaru, K., Horikoshi, M., Enomoto, S., and Kuroki, T. (1986). Growth-inhibitory effects of epidermal growth factor and overexpression of its receptors on human squamous cell carcinomas in culture. Cancer research 46, 1648-1653.
Kasahara, T., and Kasahara, M. (1997). Characterization of rat Glut4 glucose transporter expressed in the yeast Saccharomyces cerevisiae: comparison with Glut1 glucose transporter. Biochimica et biophysica acta 1324, 111-119.
Khetchoumian, K., Teletin, M., Tisserand, J., Mark, M., Herquel, B., Ignat, M., Zucman-Rossi, J., Cammas, F., Lerouge, T., Thibault, C., et al. (2007). Loss of Trim24 (Tif1alpha) gene function confers oncogenic activity to retinoic acid receptor alpha. Nature genetics 39, 1500-1506.
Kikuchi, M., Okumura, F., Tsukiyama, T., Watanabe, M., Miyajima, N., Tanaka, J., Imamura, M., and Hatakeyama, S. (2009). TRIM24 mediates ligand-dependent activation of androgen receptor and is repressed by a bromodomain-containing protein, BRD7, in prostate cancer cells. Biochimica et biophysica acta 1793, 1828-1836.
Ko, Y.C., Huang, Y.L., Lee, C.H., Chen, M.J., Lin, L.M., and Tsai, C.C. (1995). Betel quid chewing, cigarette smoking and alcohol consumption related to oral cancer in Taiwan. Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology 24, 450-453.
Krzeslak, A., Wojcik-Krowiranda, K., Forma, E., Jozwiak, P., Romanowicz, H., Bienkiewicz, A., and Brys, M. (2012). Expression of GLUT1 and GLUT3 glucose transporters in endometrial and breast cancers. Pathology oncology research : POR 18, 721-728.
Kurata, T., Oguri, T., Isobe, T., Ishioka, S., and Yamakido, M. (1999). Differential expression of facilitative glucose transporter (GLUT) genes in primary lung cancers and their liver metastases. Japanese journal of cancer research : Gann 90, 1238-1243.
Li, L., Li, C., Wang, S., Wang, Z., Jiang, J., Wang, W., Li, X., Chen, J., Liu, K., Li, C., et al. (2016). Exosomes Derived from Hypoxic Oral Squamous Cell Carcinoma Cells Deliver miR-21 to Normoxic Cells to Elicit a Prometastatic Phenotype. Cancer research 76, 1770-1780.
Li, Q., Manolescu, A., Ritzel, M., Yao, S., Slugoski, M., Young, J.D., Chen, X.Z., and Cheeseman, C.I. (2004). Cloning and functional characterization of the human GLUT7 isoform SLC2A7 from the small intestine. American journal of physiology Gastrointestinal and liver physiology 287, G236-242.
Li, S.J., Yang, X.N., and Qian, H.Y. (2015). Antitumor effects of WNT2B silencing in GLUT1 overexpressing cisplatin resistant head and neck squamous cell carcinoma. American journal of cancer research 5, 300-308.
Lieber, C.S., Baraona, E., Hernandez-Munoz, R., Kubota, S., Sato, N., Kawano, S., Matsumura, T., and Inatomi, N. (1989). Impaired oxygen utilization. A new mechanism for the hepatotoxicity of ethanol in sub-human primates. The Journal of clinical investigation 83, 1682-1690.
Liu, H., Huang, D., McArthur, D.L., Boros, L.G., Nissen, N., and Heaney, A.P. (2010). Fructose induces transketolase flux to promote pancreatic cancer growth. Cancer research 70, 6368-6376.
Liu, L., Jedrychowski, M.P., Gygi, S.P., and Pilch, P.F. (2006). Role of insulin-dependent cortical fodrin/spectrin remodeling in glucose transporter 4 translocation in rat adipocytes. Molecular biology of the cell 17, 4249-4256.
Macheda, M.L., Rogers, S., and Best, J.D. (2005). Molecular and cellular regulation of glucose transporter (GLUT) proteins in cancer. Journal of cellular physiology 202, 654-662.
Manolescu, A.R., Augustin, R., Moley, K., and Cheeseman, C. (2007). A highly conserved hydrophobic motif in the exofacial vestibule of fructose transporting SLC2A proteins acts as a critical determinant of their substrate selectivity. Molecular membrane biology 24, 455-463.
Mantych, G.J., James, D.E., and Devaskar, S.U. (1993). Jejunal/kidney glucose transporter isoform (Glut-5) is expressed in the human blood-brain barrier. Endocrinology 132, 35-40.
Masin, M., Vazquez, J., Rossi, S., Groeneveld, S., Samson, N., Schwalie, P.C., Deplancke, B., Frawley, L.E., Gouttenoire, J., Moradpour, D., et al. (2014). GLUT3 is induced during epithelial-mesenchymal transition and promotes tumor cell proliferation in non-small cell lung cancer. Cancer & metabolism 2, 11.
Matsuzu, K., Segade, F., Matsuzu, U., Carter, A., Bowden, D.W., and Perrier, N.D. (2004). Differential expression of glucose transporters in normal and pathologic thyroid tissue. Thyroid : official journal of the American Thyroid Association 14, 806-812.
McBrayer, S.K., Cheng, J.C., Singhal, S., Krett, N.L., Rosen, S.T., and Shanmugam, M. (2012). Multiple myeloma exhibits novel dependence on GLUT4, GLUT8, and GLUT11: implications for glucose transporter-directed therapy. Blood 119, 4686-4697.
McVie-Wylie, A.J., Lamson, D.R., and Chen, Y.T. (2001). Molecular cloning of a novel member of the GLUT family of transporters, SLC2a10 (GLUT10), localized on chromosome 20q13.1: a candidate gene for NIDDM susceptibility. Genomics 72, 113-117.
Medina Villaamil, V., Aparicio Gallego, G., Valbuena Rubira, L., Garcia Campelo, R., Valladares-Ayerbes, M., Grande Pulido, E., Victoria Bolos, M., Santamarina Cainzos, I., and Anton Aparicio, L.M. (2011). Fructose transporter GLUT5 expression in clear renal cell carcinoma. Oncology reports 25, 315-323.
Mellanen, P., Minn, H., Grenman, R., and Harkonen, P. (1994). Expression of glucose transporters in head-and-neck tumors. International journal of cancer 56, 622-629.
Miao, Z.F., Wang, Z.N., Zhao, T.T., Xu, Y.Y., Wu, J.H., Liu, X.Y., Xu, H., You, Y., and Xu, H.M. (2015). TRIM24 is upregulated in human gastric cancer and promotes gastric cancer cell growth and chemoresistance. Virchows Archiv : an international journal of pathology 466, 525-532.
Nagamatsu, S., Sawa, H., Wakizaka, A., and Hoshino, T. (1993). Expression of facilitative glucose transporter isoforms in human brain tumors. Journal of neurochemistry 61, 2048-2053.
Nishioka, T., Oda, Y., Seino, Y., Yamamoto, T., Inagaki, N., Yano, H., Imura, H., Shigemoto, R., and Kikuchi, H. (1992). Distribution of the glucose transporters in human brain tumors. Cancer research 52, 3972-3979.
Noguchi, Y., Marat, D., Saito, A., Yoshikawa, T., Doi, C., Fukuzawa, K., Tsuburaya, A., Satoh, S., and Ito, T. (1999). Expression of facilitative glucose transporters in gastric tumors. Hepato-gastroenterology 46, 2683-2689.
Overgaard, J., Nielsen, J.E., and Grau, C. (1992). Effect of carboxyhemoglobin on tumor oxygen unloading capacity in patients with squamous cell carcinoma of the head and neck. International journal of radiation oncology, biology, physics 22, 407-410.
Pathiraja, T.N., Thakkar, K.N., Jiang, S., Stratton, S., Liu, Z., Gagea, M., Shi, X., Shah, P.K., Phan, L., Lee, M.H., et al. (2015). TRIM24 links glucose metabolism with transformation of human mammary epithelial cells. Oncogene 34, 2836-2845.
Pujol-Gimenez, J., de Heredia, F.P., Idoate, M.A., Airley, R., Lostao, M.P., and Evans, A.R. (2015). Could GLUT12 be a Potential Therapeutic Target in Cancer Treatment? A Preliminary Report. Journal of Cancer 6, 139-143.
Reinicke, K., Sotomayor, P., Cisterna, P., Delgado, C., Nualart, F., and Godoy, A. (2012). Cellular distribution of Glut-1 and Glut-5 in benign and malignant human prostate tissue. Journal of cellular biochemistry 113, 553-562.
Rogers, S., Docherty, S.E., Slavin, J.L., Henderson, M.A., and Best, J.D. (2003). Differential expression of GLUT12 in breast cancer and normal breast tissue. Cancer letters 193, 225-233.
Rogers, S., Macheda, M.L., Docherty, S.E., Carty, M.D., Henderson, M.A., Soeller, W.C., Gibbs, E.M., James, D.E., and Best, J.D. (2002). Identification of a novel glucose transporter-like protein-GLUT-12. American journal of physiology Endocrinology and metabolism 282, E733-738.
Rudich, A., Konrad, D., Torok, D., Ben-Romano, R., Huang, C., Niu, W., Garg, R.R., Wijesekara, N., Germinario, R.J., Bilan, P.J., et al. (2003). Indinavir uncovers different contributions of GLUT4 and GLUT1 towards glucose uptake in muscle and fat cells and tissues. Diabetologia 46, 649-658.
Rumsey, S.C., Daruwala, R., Al-Hasani, H., Zarnowski, M.J., Simpson, I.A., and Levine, M. (2000). Dehydroascorbic acid transport by GLUT4 in Xenopus oocytes and isolated rat adipocytes. The Journal of biological chemistry 275, 28246-28253.
Sasaki, T., Minoshima, S., Shiohama, A., Shintani, A., Shimizu, A., Asakawa, S., Kawasaki, K., and Shimizu, N. (2001). Molecular cloning of a member of the facilitative glucose transporter gene family GLUT11 (SLC2A11) and identification of transcription variants. Biochemical and biophysical research communications 289, 1218-1224.
Scheepers, A., Schmidt, S., Manolescu, A., Cheeseman, C.I., Bell, A., Zahn, C., Joost, H.G., and Schurmann, A. (2005). Characterization of the human SLC2A11 (GLUT11) gene: alternative promoter usage, function, expression, and subcellular distribution of three isoforms, and lack of mouse orthologue. Molecular membrane biology 22, 339-351.
Shi, D., Guo, W., Chen, W., Fu, L., Wang, J., Tian, Y., Xiao, X., Kang, T., Huang, W., and Deng, W. (2012). Nicotine promotes proliferation of human nasopharyngeal carcinoma cells by regulating alpha7AChR, ERK, HIF-1alpha and VEGF/PEDF signaling. PloS one 7, e43898.
Siemann, D.W., Hill, R.P., and Bush, R.S. (1978). Smoking: the influence of carboxyhemoglobin (HbCO) on tumor oxygenation and response to radiation. International journal of radiation oncology, biology, physics 4, 657-662.
Starska, K., Forma, E., Jozwiak, P., Brys, M., Lewy-Trenda, I., Brzezinska-Blaszczyk, E., and Krzeslak, A. (2015). Gene and protein expression of glucose transporter 1 and glucose transporter 3 in human laryngeal cancer-the relationship with regulatory hypoxia-inducible factor-1alpha expression, tumor invasiveness, and patient prognosis. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 36, 2309-2321.
Stockhammer, F., von Deimling, A., Synowitz, M., Blechschmidt, C., and van Landeghem, F.K. (2008). Expression of glucose transporter 1 is associated with loss of heterozygosity of chromosome 1p in oligodendroglial tumors WHO grade II. Journal of molecular histology 39, 553-560.
Su, Z.Z., Sarkar, D., Emdad, L., Barral, P.M., and Fisher, P.B. (2007). Central role of interferon regulatory factor-1 (IRF-1) in controlling retinoic acid inducible gene-I (RIG-I) expression. Journal of cellular physiology 213, 502-510.
Sun, W., Liu, Y., Glazer, C.A., Shao, C., Bhan, S., Demokan, S., Zhao, M., Rudek, M.A., Ha, P.K., and Califano, J.A. (2010). TKTL1 is activated by promoter hypomethylation and contributes to head and neck squamous cell carcinoma carcinogenesis through increased aerobic glycolysis and HIF1alpha stabilization. Clinical cancer research : an official journal of the American Association for Cancer Research 16, 857-866.
Suzawa, N., Ito, M., Qiao, S., Uchida, K., Takao, M., Yamada, T., Takeda, K., and Murashima, S. (2011). Assessment of factors influencing FDG uptake in non-small cell lung cancer on PET/CT by investigating histological differences in expression of glucose transporters 1 and 3 and tumour size. Lung cancer (Amsterdam, Netherlands) 72, 191-198.
Teyssier, C., Ou, C.Y., Khetchoumian, K., Losson, R., and Stallcup, M.R. (2006). Transcriptional intermediary factor 1alpha mediates physical interaction and functional synergy between the coactivator-associated arginine methyltransferase 1 and glucocorticoid receptor-interacting protein 1 nuclear receptor coactivators. Molecular endocrinology (Baltimore, Md) 20, 1276-1286.
Thakkar, K.N., Stratton, S.A., and Craig Barton, M. (2015). Tissue-specific metabolism and TRIM24. Aging 7, 736-737.
Thenot, S., Henriquet, C., Rochefort, H., and Cavailles, V. (1997). Differential interaction of nuclear receptors with the putative human transcriptional coactivator hTIF1. The Journal of biological chemistry 272, 12062-12068.
Tisserand, J., Khetchoumian, K., Thibault, C., Dembele, D., Chambon, P., and Losson, R. (2011). Tripartite motif 24 (Trim24/Tif1alpha) tumor suppressor protein is a novel negative regulator of interferon (IFN)/signal transducers and activators of transcription (STAT) signaling pathway acting through retinoic acid receptor alpha (Raralpha) inhibition. The Journal of biological chemistry 286, 33369-33379.
Tsai, W.W., Wang, Z., Yiu, T.T., Akdemir, K.C., Xia, W., Winter, S., Tsai, C.Y., Shi, X., Schwarzer, D., Plunkett, W., et al. (2010). TRIM24 links a non-canonical histone signature to breast cancer. Nature 468, 927-932.
Uldry, M., Ibberson, M., Hosokawa, M., and Thorens, B. (2002). GLUT2 is a high affinity glucosamine transporter. FEBS letters 524, 199-203.
Vander Heiden, M.G., Cantley, L.C., and Thompson, C.B. (2009). Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science (New York, NY) 324, 1029-1033.
Vaz, C.V., Marques, R., Alves, M.G., Oliveira, P.F., Cavaco, J.E., Maia, C.J., and Socorro, S. (2016). Androgens enhance the glycolytic metabolism and lactate export in prostate cancer cells by modulating the expression of GLUT1, GLUT3, PFK, LDH and MCT4 genes. Journal of cancer research and clinical oncology 142, 5-16.
Vermorken, J.B., Mesia, R., Rivera, F., Remenar, E., Kawecki, A., Rottey, S., Erfan, J., Zabolotnyy, D., Kienzer, H.R., Cupissol, D., et al. (2008). Platinum-based chemotherapy plus cetuximab in head and neck cancer. The New England journal of medicine 359, 1116-1127.
Wu, C.H., Ho, Y.S., Tsai, C.Y., Wang, Y.J., Tseng, H., Wei, P.L., Lee, C.H., Liu, R.S., and Lin, S.Y. (2009a). In vitro and in vivo study of phloretin-induced apoptosis in human liver cancer cells involving inhibition of type II glucose transporter. International journal of cancer 124, 2210-2219.
Wu, H.G., Song, S.Y., Kim, Y.S., Oh, Y.T., Lee, C.G., Keum, K.C., Ahn, Y.C., and Lee, S.W. (2009b). Therapeutic effect of recombinant human epidermal growth factor (RhEGF) on mucositis in patients undergoing radiotherapy, with or without chemotherapy, for head and neck cancer: a double-blind placebo-controlled prospective phase 2 multi-institutional clinical trial. Cancer 115, 3699-3708.
Wu, X., and Freeze, H.H. (2002). GLUT14, a duplicon of GLUT3, is specifically expressed in testis as alternative splice forms. Genomics 80, 553-557.
Wu, X., Li, W., Sharma, V., Godzik, A., and Freeze, H.H. (2002). Cloning and characterization of glucose transporter 11, a novel sugar transporter that is alternatively spliced in various tissues. Molecular genetics and metabolism 76, 37-45.
Xue, D., Zhang, X., Zhang, X., Liu, J., Li, N., Liu, C., Liu, Y., and Wang, P. (2015). Clinical significance and biological roles of TRIM24 in human bladder carcinoma. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 36, 6849-6855.
Yamamoto, T., Seino, Y., Fukumoto, H., Koh, G., Yano, H., Inagaki, N., Yamada, Y., Inoue, K., Manabe, T., and Imura, H. (1990). Over-expression of facilitative glucose transporter genes in human cancer. Biochemical and biophysical research communications 170, 223-230.
Yang, M.H., Wu, M.Z., Chiou, S.H., Chen, P.M., Chang, S.Y., Liu, C.J., Teng, S.C., and Wu, K.J. (2008). Direct regulation of TWIST by HIF-1alpha promotes metastasis. Nature cell biology 10, 295-305.
Younes, M., Brown, R.W., Mody, D.R., Fernandez, L., and Laucirica, R. (1995). GLUT1 expression in human breast carcinoma: correlation with known prognostic markers. Anticancer research 15, 2895-2898.
Younes, M., Lechago, L.V., Somoano, J.R., Mosharaf, M., and Lechago, J. (1997). Immunohistochemical detection of Glut3 in human tumors and normal tissues. Anticancer research 17, 2747-2750.
Zamora-Leon, S.P., Golde, D.W., Concha, II, Rivas, C.I., Delgado-Lopez, F., Baselga, J., Nualart, F., and Vera, J.C. (1996). Expression of the fructose transporter GLUT5 in human breast cancer. Proceedings of the National Academy of Sciences of the United States of America 93, 1847-1852.
Zhang, L.H., Yin, A.A., Cheng, J.X., Huang, H.Y., Li, X.M., Zhang, Y.Q., Han, N., and Zhang, X. (2015). TRIM24 promotes glioma progression and enhances chemoresistance through activation of the PI3K/Akt signaling pathway. Oncogene 34, 600-610.
Zhao, F.Q., and Keating, A.F. (2007). Functional properties and genomics of glucose transporters. Current genomics 8, 113-128.
Zhou, J.Y., Jiang, Z.A., Zhao, C.Y., Zhen, Z., Wang, W., and Nanji, A.A. (2013). Long-term binge and escalating ethanol exposure causes necroinflammation and fibrosis in rat liver. Alcoholism, clinical and experimental research 37, 213-222.
|